VX-147

VX-147 · Vertex Pharmaceuticals Incorporated

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for VX-147, covering 2023-07-10 to 2026-04-17. Get the full timeline:

Most recent: Clinical Trial Update: Phase 2/3 Adaptive Study of VX-147 in Adult and Pediatric Participants With APOL1-Mediated Proteinuric Kidney Disease [Phase 2, Phase 3]

See pricing